title: Tiotropium Respimat increases the risk of mortality.
authors.forename: Christine R
authors.initials: CR
authors.lastname: Jenkins
authors.forename: Richard
authors.initials: R
authors.lastname: Beasley
mesh_terms: D000280:Administration, Inhalation; D001993:Bronchodilator Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002423:Cause of Death; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000139:chemically induced / Q000401:mortality; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy* / Q000401:mortality*; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D012602:Scopolamine Derivatives / Q000009:adverse effects* / Q000627:therapeutic use; D020521:Stroke / Q000139:chemically induced / Q000401:mortality; D016019:Survival Analysis; D000069447:Tiotropium Bromide; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D001993:Bronchodilator Agents; D012602:Scopolamine Derivatives; D000069447:Tiotropium Bromide